Di-tert-butyl dicarbonate CAS 24424-99-5, molecular weight 218.25 g/mol, is supplied as low-melting white solid with assay ≥99.0% w/w, water content by Karl Fischer titration ≤0.20% w/w, and melting range 22–24 °C. Industrial use is restricted to synthetic routes in which an acid-labile tert-butoxycarbonyl group is required to protect primary or secondary amines—or, less commonly, phenols—during subsequent processing. The following application scenarios are limited to verified downstream sectors: solid-phase peptide synthesis building blocks, small molecule pharmaceutical intermediates, photoresist polymer modification, agrochemical intermediate synthesis, heterobifunctional PEG linker manufacturing, and orthogonally protected unnatural amino acid derivatives.

In solid-phase peptide synthesis, di-tert-butyl dicarbonate is introduced during the preparation of N-α-Boc-amino acid building blocks rather than as a direct deprotection reagent in Fmoc-mediated chain assembly. The reagent is charged at 1.05–1.30 mol per mole of free amino acid in a 1,4-dioxane:water 2:1 v/v solvent system, while the reaction temperature is maintained at 0–10 °C for the first 30–60 min and allowed to rise to 20–25 °C thereafter. The pH is held at 9–11 by controlled addition of 2.0 M aqueous sodium hydroxide; failure to maintain pH above 9 results in incomplete carbamoylation, while pH excursions above 11 accelerate hydrolysis of the reagent to tert-butanol and carbon dioxide. The exotherm and off-gassing profile on 500 L scale require jacket chilled-water supply at 2–5 °C and a vent line sized for 1.0–1.2 mol CO₂ per mole of dicarbonate consumed. After phase separation, the N-Boc amino acid is crystallized from ethyl acetate/heptane to yield material with residual starting amino acid below 0.5% w/w by HPLC area percent. Downstream, the N-Boc amino acid is used directly in Boc-protocol SPPS or in solution-phase peptide fragment coupling; for Fmoc-protocol SPPS, N-Boc amino acids are selectively deprotected and then Fmoc-protected after side-chain masking. Terminal peptide APIs produced through this route include therapeutic peptides requiring ≥98.0% chromatographic purity and residual trifluoroacetic acid below 0.1% w/w after lyophilization. Compliance requirements include ICH Q7 Section 8.1 for production controls, USP <467> for residual dioxane and heptane, and USP <621> for HPLC assay.

Why N-Boc Chiral Amine Intermediates Appear in Small Molecule API Manufacturing

Within small molecule API campaigns, di-tert-butyl dicarbonate is charged to protected primary or secondary amines as a transient masking group enabling subsequent alkylation, reductive amination, or metal-catalyzed coupling to occur without N-functionalization side reactions. The reagent is added at 1.0–1.5 mol per mole of amine in anhydrous dichloromethane or tetrahydrofuran; when the substrate is poorly nucleophilic, 0.1–1.0 mol% 4-dimethylaminopyridine is co-charged and the mixture is stirred at 20–40 °C for 4–24 h. Use of a nitrogen atmosphere and pre-dried solvent is mandatory because residual water consumes dicarbonate and releases CO₂, causing pressure rise in closed reactors. On 200–2,000 L campaigns, reactor charging is performed with a solids addition system capable of 5–20 kg/h feed rate to avoid localized reagent concentration above 0.5 M; higher local concentration leads to symmetric urea side-product formation via reaction of the desired N-Boc intermediate with unreacted free amine. After washing with aqueous citric acid and brine, the intermediate is concentrated and carried forward or crystallized. Terminal products from such N-Boc intermediates are small molecule APIs, particularly oncology and antiviral compounds where the Boc-protected amine is deprotected with HCl/dioxane or trifluoroacetic acid and isolated as the hydrochloride or free base. Compliance controls follow ICH M7 for mutagenic impurity risk assessment of alkyl halide or urea side products, ICH Q3D for elemental impurities from metal catalysts, and USP <467> for residual dichloromethane and tetrahydrofuran. Analytical limits are set at ≤0.1% w/w for individual unknown impurities above the 0.10% identification threshold.

When 4-hydroxystyrene/methacrylate copolymers are modified for chemically amplified DUV photoresist formulations, di-tert-butyl dicarbonate transforms pendant phenol groups into tert-butoxycarbonyl-protected phenols with acid-labile deprotection behavior. The post-polymerization modification is carried out in propylene glycol monomethyl ether acetate or tetrahydrofuran at 25–40 °C using 0.5–2.0 mol dicarbonate per mole of hydroxyl, with triethylamine or dimethylaminopyridine at 0.1–0.5 mol% as catalyst. The addition ratio is adjusted to a target blocking ratio because aqueous base solubility, glass transition temperature, and post-exposure bake deprotection temperature shift with degree of protection; partially protected polymers with 20–30 mol% Boc blocking exhibit clearing dose and contrast suitable for 248 nm lithography. After modification, the polymer is precipitated into hexane or heptane/water, filtered, and redissolved in PGMEA to 10–15 wt% solids. The downstream process includes filtration through 0.1 μm PTFE membrane and evaluation of dark film thickness loss, contrast curve, and line-space resolution. Terminal product is a chemically amplified photoresist polymer component supplied to resist formulators; it is not a formulated photoresist. Compliance obligations include REACH (EC) No 1907/2006 for EU market access, ISO 9001:2015 for lot traceability, and ISO 14644-1:2015 Class 5 cleanroom handling because trace metallic impurities must be below 100 ppb for sodium, iron, and chromium by ICP-MS to prevent gate oxide degradation. Published data for specific lithographic performance at sub-100 nm nodes is limited for this exact polymer modification route because resist evaluation is formulation-specific.

Transient Amine Masking in Agrochemical Intermediate Synthesis

Agrochemical routes to pyrazole carboxamide, aminopyrimidine, or thiazole-containing active ingredients frequently protect a primary aromatic or heterocyclic amine before halogenation, sulfonylation, or palladium-catalyzed cross-coupling. Di-tert-butyl dicarbonate is charged at 1.0–1.2 mol per mole of amine in tert-butanol or dichloromethane with 1.0–1.2 mol sodium bicarbonate or triethylamine; the reaction is run at 25–40 °C for 12–24 h under nitrogen. Off-gassing of CO₂ must be vented, and the headspace is monitored for pressure excursions on sealed reactors above 50 L capacity. The resulting N-Boc heterocyclic amine is carried into downstream steps without isolation, followed by acidic deprotection using HCl in dioxane or aqueous methanesulfonic acid to regenerate the free amine. Terminal products are agrochemical active ingredients, primarily fungicidal and herbicidal actives in the pyrazole and pyrimidine classes. Regulatory compliance for the intermediate and final active ingredient follows EU REACH and, for products exported to North America, EPA 40 CFR Part 180 residue chemistry data requirements for food-use crops; the manufacturing site typically applies ISO 14001:2015 environmental management because aqueous workup generates bicarbonate/tert-butanol waste streams. Residual tert-butanol in the isolated intermediate is controlled to below 0.5% w/w by GC headspace per internal specification aligned with USP <467> method formats.

Aminofunctionalized monomethoxy poly(ethylene glycol) with molecular weight 2,000–5,000 Da is commonly produced with a tert-butoxycarbonyl-protected amine during chain extension and activation steps. Di-tert-butyl dicarbonate is introduced at 1.5–2.0 mol per mole of terminal primary amine in a dichloromethane/water biphasic mixture buffered with sodium bicarbonate to pH 8–9 at 20–25 °C for 6–18 h. Excess reagent is used because PEG-bound amines exhibit lower reactivity than small molecule amines and because moisture absorbed in the PEG matrix consumes dicarbonate. After phase separation, the Boc-protected PEG amine is isolated by precipitation in methyl tert-butyl ether at −10 to 0 °C and dried under vacuum at 25 °C to water content below 0.10% w/w. The protected intermediate undergoes further transformation—heterobifunctional carboxylation, maleimide introduction, or NHS-ester activation—before final Boc deprotection under trifluoroacetic acid/dichloromethane 50% v/v to release the free amine. Terminal product types include amino-PEG carboxylic acids, maleimide-PEG-amine linkers, and biotin-PEG-amine conjugates produced as both disperse and chromatographically purified single chain-length grades used in downstream bioconjugation and diagnostic reagent manufacturing. Compliance for these derivatives follows ISO 13485:2016 where contract manufacturers serve medical device and IVD component supply chains, and ICH Q7 when the linkers are used in clinical-stage antibody-drug conjugate manufacture. Lot release includes MALDI-TOF mass spectrometry for molecular weight distribution, ¹H NMR for Boc group content, and USP <467> headspace GC for residual methyl tert-butyl ether and dichloromethane below pharmacopeial limits.

When Unnatural Amino Acid Crystallization Requires Orthogonal Protection

When β-amino esters, N-methyl amino acids, or constrained bicyclic amino acid scaffolds are manufactured for peptide mimetic and medicinal chemistry programs, N-Boc protection is selected because the tert-butoxycarbonyl group remains stable during ester hydrolysis, reductive alkylation, and hydrogenolysis steps that cleave benzyl or Cbz groups. Di-tert-butyl dicarbonate is introduced at 1.0–1.2 mol per mole of amino ester in tetrahydrofuran with 1.0–1.5 mol sodium bicarbonate and stirred at 0–25 °C for 8–16 h. Lower temperatures are used for β-amino esters prone to base-catalyzed retro-Michael elimination; the exotherm is controlled by adding the reagent in 0.2–0.5 mol portions, and the reaction is monitored by HPLC to avoid overprotection of unprotected hydroxyl groups. The downstream process isolates the N-Boc amino acid by solvent exchange to methyl tert-butyl ether, washing with 10% w/v aqueous citric acid, and crystallization from n-heptane/ethyl acetate. Terminal products are orthogonally protected amino acid derivatives, including N-Boc-trans-β-amino precursors and N-Boc-N-methyl amino acids, supplied to peptide synthesizers and CDMO laboratories. Compliance is governed by ICH Q7 for later API intermediate use, and analytical release includes chiral HPLC per USP <621> with enantiomeric excess above 99.0% and achiral HPLC purity above 98.0%. The operational boundary is strict: residual water above 0.5% w/w in the solvent system reduces yield and increases turbidity of the final crystallization because tert-butanol and di-tert-butyl carbonate hydrolysis products persist in the mother liquor.